Betaxolol Market Expand Steadily in the Coming Years
Betaxolol is a special beta-receptor, primarily used to treat a medical conditions such as hypertension and glaucoma. It was first officially approved by the U.S. Food and Drug Administration (FDA) as an oral tablet in 1989. It can be used alone or in combination with other medicines to reduce the pressure within the heart or eye. Betaxolol decrease the rate of cardiac contractility selectively and actively bind and block beta-1 adrenergic receptors, which leads to a reduction in cardiac output...
View full press release